Vascular Effects of Sitagliptin in Diabetes Mellitus

NCT01096277 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo
OTHER: Control

Sponsor

Hannover Medical School